Skip to main content

Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

Retraction

This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.

References

  1. 1.

    Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Neil D Jelly.

Additional information

The online version of the original article can be found at 10.1186/1475-2867-12-21

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Cite this article

Jelly, N.D., Hussain, I.I., Eremin, J. et al. Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int 13, 96 (2013). https://doi.org/10.1186/1475-2867-13-96

Download citation